131 related articles for article (PubMed ID: 12509695)
1. Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure.
Abraham P; Ralston SH; Hewison M; Fraser WD; Bevan JS
Postgrad Med J; 2002 Dec; 78(926):752-3. PubMed ID: 12509695
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
[TBL] [Abstract][Full Text] [Related]
3. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
5. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
[No Abstract] [Full Text] [Related]
6. Parathyroid hormone related protein (PTHrP) mediated hypercalcaemia complicating enteropancreatic malignancy in multiple endocrine neoplasia type 1 (MEN 1).
Burgess JR; Wilkinson S; Lowenthal RM
Aust N Z J Med; 2000 Apr; 30(2):280-1. PubMed ID: 10833127
[No Abstract] [Full Text] [Related]
7. Expression and processing of parathyroid hormone-related protein in a pancreatic endocrine cell tumour associated with hypercalcaemia.
Ratcliffe WA; Bowden SJ; Dunne FP; Hughes S; Emly JF; Baker JT; Pye JK; Williams CP
Clin Endocrinol (Oxf); 1994 May; 40(5):679-86. PubMed ID: 8013148
[TBL] [Abstract][Full Text] [Related]
8. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor.
Van den Eynden GG; Neyret A; Fumey G; Rizk-Rabin M; Vermeulen PB; Bouizar Z; Body JJ; Dirix LY
Bone; 2007 Apr; 40(4):1166-71. PubMed ID: 17188588
[TBL] [Abstract][Full Text] [Related]
9. Case report: lanreotide in the management of hypercalcemia of malignancy.
Anthony LB; May ME; Oates JA
Am J Med Sci; 1995 Jun; 309(6):312-4. PubMed ID: 7771500
[TBL] [Abstract][Full Text] [Related]
10. Case report: life-threatening hypercalcaemia secondary to pancreatic tumour secreting parathyroid hormone-related protein--successful control by hepatic arterial embolization.
Tarver DS; Birch SJ
Clin Radiol; 1992 Sep; 46(3):204-5. PubMed ID: 1395428
[TBL] [Abstract][Full Text] [Related]
11. Humoral hypercalcaemia in renal carcinoma due to parathyroid hormone related protein.
Sandhu DP; Munson KW; Harrop JS; Hopton MR; Ratcliffe WA
Br J Urol; 1993 Dec; 72(6):848-50. PubMed ID: 8306145
[TBL] [Abstract][Full Text] [Related]
12. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia as the first finding of late recurrence of a PTHrP neuroendocrine tumor of the pancreas.
Febrero B; Gómez B; Ruiz-Manzanera JJ; Ros-Madrid I; Rodríguez JM
Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):31-32. PubMed ID: 38350837
[No Abstract] [Full Text] [Related]
14. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia.
Bandyopadhyay P; Baksi S; Bandyopadhyay D; Patel CU
Int J Clin Pract; 2003 Mar; 57(2):140-2. PubMed ID: 12661799
[TBL] [Abstract][Full Text] [Related]
16. Rare case of pancreatic neuroendocrine tumour presenting as paraneoplastic hypercalcaemia.
Ferrel B; Franko J; Tee MC
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33858893
[TBL] [Abstract][Full Text] [Related]
17. Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.
Hutchesson AC; Bundred NJ; Ratcliffe WA
Postgrad Med J; 1995 Jan; 71(831):28-31. PubMed ID: 7708588
[TBL] [Abstract][Full Text] [Related]
18. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
Milanesi A; Yu R; Wolin EM
Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
